发明名称 |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
摘要 |
A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer. |
申请公布号 |
US8974827(B2) |
申请公布日期 |
2015.03.10 |
申请号 |
US200812451810 |
申请日期 |
2008.05.26 |
申请人 |
Bend Research, Inc. |
发明人 |
Bloom Corey Jay;Crew Marshall David;Miller Warren Kenyon;Morgen Michael Mark;Smithey Daniel Tod |
分类号 |
A61K9/14;A61K9/00;A61K31/47;A61K31/42;A61K31/415;A01N43/40;A01N43/80;A01N43/56;A61K9/51;A61K31/435;A61K47/34;A61K47/38 |
主分类号 |
A61K9/14 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A pharmaceutical composition comprising nanoparticles, said nanoparticles consisting of:
(a) a drug having a solubility in water of less than 5 mg/mL over the pH range of 6.5 to 7.5 at 25° C., at least 90 wt % of said drug being non-crystalline; (b) a poorly aqueous soluble non-ionizable cellulosic polymer selected from the group consisting of ethylcellulose, cellulose acetate, cellulose propionate, cellulose butyrate, cellulose acetate butyrate, and mixtures thereof; and (c) a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer, wherein the amphilphilic non-ionizable copolymer is poly(ethylene oxide-b-ε-caprolactone);wherein said nanoparticles have an average size of less than 500 nm; and comprise from 1 wt % to 80 wt % said drug, from 10 wt % to 75 wt % said non-ionizable cellulosic polymer, and from 5 wt % to 60 wt % said amphiphilic non-ionizable block copolymer. |
地址 |
Bend OR US |